ArticlePharmaceutics2026

Genetically Engineered Biomimetic Nanovesicles Co-Deliveing a Checkpoint Inhibitor and Doxorubicin for Enhanced Cancer Chemo-Immunotherapy.

Yunying Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.